January 23, 2014 / 7:06 AM / 4 years ago

BRIEF-MDxHealth signs deal with Teva for commercialization of two cancer tests

1 Min Read

BRUSSELS, Jan 23 (Reuters) - MDxHealth SA : * Announces agreement with Teva Pharmaceuticals for commercialization of two cancer tests in Israel * Three-year deal for commercialization of Confirmmdx for prostate cancer,

Predictmdx for glioblastoma tests in Israel

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below